Influence of clinically significant portal hypertension on surgical outcomes and survival following hepatectomy for hepatocellular carcinoma: A systematic review and meta-analysis

Journal of Hepato-Biliary-Pancreatic Sciences

Volumn 21, Issue 9, 2014, Pages 639-647

  Choi, Sae Byeol ^a   Kim, Hyun Jung ^a   Song, Tae Jin ^a   Ahn, Hyeong Sik ^a   Choi, Sang Yong ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

Hepatectomy; Hepatocellular carcinoma; Liver failure; Portal hypertension

Indexed keywords

CANCER MORTALITY; CANCER PROGNOSIS; CANCER SURVIVAL; ESOPHAGUS VARICES; HUMAN; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER RESECTION; META ANALYSIS; MORBIDITY; OVERALL SURVIVAL; PORTAL HYPERTENSION; POSTOPERATIVE COMPLICATION; REVIEW; SENSITIVITY ANALYSIS; SPLENOMEGALY; SURGICAL MORTALITY; SYSTEMATIC REVIEW; THROMBOCYTOPENIA; TREATMENT OUTCOME; TUMOR INVASION; CARCINOMA, HEPATOCELLULAR; COMPLICATION; LIVER NEOPLASMS; MORTALITY; PRACTICE GUIDELINE; SURVIVAL RATE;

CARCINOMA, HEPATOCELLULAR; HEPATECTOMY; HUMANS; HYPERTENSION, PORTAL; LIVER NEOPLASMS; POSTOPERATIVE COMPLICATIONS; PRACTICE GUIDELINES AS TOPIC; SURVIVAL RATE;

EID: 84906335266     PISSN: 18686974     EISSN: 18686982     Source Type: Journal    
DOI: 10.1002/jhbp.124     Document Type: Review

References (41)

1. Llovet JM, Bru C, Bruix J,. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis. 1999; 19: 329-338.
2. Llovet JM, Fuster J, Bruix J,. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology. 1999; 30: 1434-1440.
3. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996; 334: 693-699.
4. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R,. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973; 60: 646-649.
5. Lee SG, Hwang S,. How I do it: assessment of hepatic functional reserve for indication of hepatic resection. J Hepatobiliary Pancreat Surg. 2005; 12: 38-43.
6. Makuuchi M, Kosuge T, Takayama T, Yamazaki S, Kakazu T, Miyagawa S, et al. Surgery for small liver cancers. Semin Surg Oncol. 1993; 9: 298-304.
7. Bruix J, Castells A, Bosch J, Feu F, Fuster J, Garcia-Pagan JC, et al. Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology. 1996; 111: 1018-1022.
8. de Franchis R,. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol. 2005; 43: 167-176.
9. de Franchis R, Baveno VF,. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol. 2010; 53: 762-768.
10. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa: Ottawa Health Research Institute (OHRI); 2006.
11. An M, Park JW, Shin JA, Choi JI, Kim TH, Kim SH, et al. The adverse effect of indirectly diagnosed portal hypertension on the complications and prognosis after hepatic resection of hepatocellular carcinoma. Korean J Hepatol. 2006; 12: 553-561.
12. Capussotti L, Ferrero A, Vigano L, Muratore A, Polastri R, Bouzari H,. Portal hypertension: contraindication to liver surgery? World J Surg. 2006; 30: 992-999.
13. Choi GH, Park JY, Hwang HK, Kim DH, Kang CM, Choi JS, et al. Predictive factors for long-term survival in patients with clinically significant portal hypertension following resection of hepatocellular carcinoma. Liver Int. 2011; 31: 485-493.
14. Cucchetti A, Ercolani G, Vivarelli M, Cescon M, Ravaioli M, Ramacciato G, et al. Is portal hypertension a contraindication to hepatic resection? Ann Surg. 2009; 250: 922-928.
15. Giannini EG, Savarino V, Farinati F, Ciccarese F, Rapaccini G, Marco MD, et al. Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients. Liver Int. 2013; 33: 1594-1600.
16. Ishizawa T, Hasegawa K, Aoki T, Takahashi M, Inoue Y, Sano K, et al. Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma. Gastroenterology. 2008; 134: 1908-1916.
17. Kawano Y, Sasaki A, Kai S, Endo Y, Iwaki K, Uchida H, et al. Short- and long-term outcomes after hepatic resection for hepatocellular carcinoma with concomitant esophageal varices in patients with cirrhosis. Ann Surg Oncol. 2008; 15: 1670-1676.
18. Kondo K, Chijiiwa Y, Otani K, Kai M, Ohuchida J, Chijiiwa K,. Characteristics and surgical outcome of HCC patients with low platelet count. Hepatogastroenterology. 2012; 59: 2269-2272.
19. Maithel SK, Kneuertz PJ, Kooby DA, Scoggins CR, Weber SM, Martin RC, et al. Importance of low preoperative platelet count in selecting patients for resection of hepatocellular carcinoma: a multi-institutional analysis. J Am Coll Surg. 2011; 212: 638-648; discussion 648-50.
20. Ruzzenente A, Valdegamberi A, Campagnaro T, Conci S, Pachera S, Iacono C, et al. Hepatocellular carcinoma in cirrhotic patients with portal hypertension: is liver resection always contraindicated? World J Gastroenterol. 2011; 17: 5083-5088.
21. Santambrogio R, Kluger MD, Costa M, Belli A, Barabino M, Laurent A, et al. Hepatic resection for hepatocellular carcinoma in patients with Child-Pugh's A cirrhosis: is clinical evidence of portal hypertension a contraindication? HPB. 2013; 15: 78-84.
22. Deeks JJ, Higgins JPT, Altman DG,. Analysing and presenting results. In:, Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions. Chichester: John Wiley and Sons; 2006. p. 97-166.
23. Bruix J, Sherman M, Practice Guidelines Committee AASLD. Management of hepatocellular carcinoma. Hepatology. 2005; 42: 1208-1236.
24. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol. 2001; 35: 421-430.
25. Hernandez-Gea V, Turon F, Berzigotti A, Villanueva A,. Management of small hepatocellular carcinoma in cirrhosis: focus on portal hypertension. World J Gastroenterol. 2013; 19: 1193-1199.
26. Poon RT, Fan ST, Lo CM, Liu CL, Lam CM, Yuen WK, et al. Extended hepatic resection for hepatocellular carcinoma in patients with cirrhosis: is it justified? Ann Surg. 2002; 236: 602-611.
27. Foucher J, Chanteloup E, Vergniol J, Castera L, Le Bail B, Adhoute X, et al. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut. 2006; 55: 403-408.
28. Berzigotti A, Seijo S, Arena U, Abraldes JG, Vizzutti F, Garcia-Pagan JC, et al. Elastography, spleen size, and platelet count identify portal hypertension in patients with compensated cirrhosis. Gastroenterology. 2013; 144: 102-111.
29. Llop E, Berzigotti A, Reig M, Erice E, Reverter E, Seijo S, et al. Assessment of portal hypertension by transient elastography in patients with compensated cirrhosis and potentially resectable liver tumors. J Hepatol. 2012; 56: 103-108.
30. Wong TC, Lo CM,. Resection strategies for hepatocellular carcinoma. Semin Liver Dis. 2013; 33: 273-281.
31. Melendez JA, Arslan V, Fischer ME, Wuest D, Jarnagin WR, Fong Y, et al. Perioperative outcomes of major hepatic resections under low central venous pressure anesthesia: blood loss, blood transfusion, and the risk of postoperative renal dysfunction. J Am Coll Surg. 1998; 187: 620-625.
32. Poon RT, Fan ST, Lo CM, Liu CL, Lam CM, Yuen WK, et al. Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1222 consecutive patients from a prospective database. Ann Surg. 2004; 240: 698-708; discussion 708-10.
33. Yang T, Zhang J, Lu JH, Yang GS, Wu MC, Yu WF,. Risk factors influencing postoperative outcomes of major hepatic resection of hepatocellular carcinoma for patients with underlying liver diseases. World J Surg. 2011; 35: 2073-2082.
34. Fan ST, Mau Lo C, Poon RT, Yeung C, Leung Liu C, Yuen WK, et al. Continuous improvement of survival outcomes of resection of hepatocellular carcinoma: a 20-year experience. Ann Surg. 2011; 253: 745-758.
35. Onaca N, Davis GL, Jennings LW, Goldstein RM, Klintmalm GB,. Improved results of transplantation for hepatocellular carcinoma: a report from the International Registry of Hepatic Tumors in Liver Transplantation. Liver Transpl. 2009; 15: 574-580.
36. Shetty K, Timmins K, Brensinger C, Furth EE, Rattan S, Sun W, et al. Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome. Liver Transpl. 2004; 10: 911-918.
37. Earl TM, Chapman WC,. Hepatocellular carcinoma: resection versus transplantation. Semin Liver Dis. 2013; 33: 282-292.
38. Cherqui D, Laurent A, Mocellin N, Tayar C, Luciani A, Van Nhieu JT, et al. Liver resection for transplantable hepatocellular carcinoma: long-term survival and role of secondary liver transplantation. Ann Surg. 2009; 250: 738-746.
39. Poon RT, Fan ST,. Hepatectomy for hepatocellular carcinoma: patient selection and postoperative outcome. Liver Transpl. 2004; 10: S39-45.
40. Ruzzenente A, Capra F, Pachera S, Iacono C, Piccirillo G, Lunardi M, et al. Is liver resection justified in advanced hepatocellular carcinoma? Results of an observational study in 464 patients. J Gastrointest Surg. 2009; 13: 1313-1320.
41. Du M, Chen L, Zhao J, Tian F, Zeng H, Tan Y, et al. Microvascular invasion (MVI) is a poorer prognostic predictor for small hepatocellular carcinoma. BMC Cancer. 2014; 14: 38.